Ex Parte Grimm et al - Page 4



          Appeal No. 2005-0708                                                        
          Application No. 09/968,967                                                  

          OPINION                                                                     
               A.  The Rejection over Medelnick                                       
               The examiner finds that Medelnick discloses goniochromatic             
          pigments, alone or in combination with other pigments, in                   
          compositions for use as lipsticks, eye shadow, and eyeliner                 
          (Answer, page 3).  The examiner further finds that Medelnick                
          teaches compositions containing lipophilic continuous phases with           
          a goniochromatic pigment in an amount from 1-50%, with a                    
          particulate phase comprising 2.4-65% of the composition, and                
          additional pigments are exemplified in amounts of 0.5-0.9%                  
          (Answer, page 4).  From these findings, the examiner concludes              
          that it would have been obvious to one of ordinary skill in this            
          art to discover the optimum amounts of each type of pigment                 
          within the ranges taught by Medelnick (Answer, paragraph bridging           
          pages 4-5).  We agree.                                                      
               Appellants argue that none of the 45 examples in Medelnick             
          specify exactly which goniochromatic pigment is used, but the               
          examples only recite “gloss pigment” and their exact composition            
          for any specific example is not provided (Brief, page 8; Reply              
          Brief, page 3).  Appellants further argue that it is unclear if             
          any of the compositions of the examples in Medelnick have layers            

                                          4                                           




Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007